Use of PET Imaging to Evaluate Transporter-Mediated Drug-Drug Interactions.
about
Recent advances in understanding hepatic drug transportEffect of P-glycoprotein inhibition at the blood-brain barrier on brain distribution of (R)-[11 C]verapamil in elderly vs. young subjects.Influence of breast cancer resistance protein and P-glycoprotein on tissue distribution and excretion of Ko143 assessed with PET imaging in mice.Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography.Synthesis of 11C-Labelled Ureas by Palladium(II)-Mediated Oxidative Carbonylation.Preclinical Evaluation of [F]LCATD as a PET Tracer to Study Drug-Drug Interactions Caused by Inhibition of Hepatic Transporters
P2860
Use of PET Imaging to Evaluate Transporter-Mediated Drug-Drug Interactions.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Use of PET Imaging to Evaluate Transporter-Mediated Drug-Drug Interactions.
@en
type
label
Use of PET Imaging to Evaluate Transporter-Mediated Drug-Drug Interactions.
@en
prefLabel
Use of PET Imaging to Evaluate Transporter-Mediated Drug-Drug Interactions.
@en
P2860
P356
P1476
Use of PET Imaging to Evaluate Transporter-Mediated Drug-Drug Interactions
@en
P2093
Oliver Langer
P2860
P304
P356
10.1002/JCPH.722
P478
56 Suppl 7
P577
2016-07-01T00:00:00Z